Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("SHAO, Yu-Yun")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 14 of 14

  • Page / 1
Export

Selection :

  • and

Pleural metastases as a unique entity with dismal outcome of head and neck squamous cell carcinomaSHAO, Yu-Yun; HONG, Ruey-Long.Oral oncology (1997). 2010, Vol 46, Num 9, pp 694-697, issn 1368-8375, 4 p.Article

Fatal Thrombocytopenia after Oxaliplatin-based ChemotherapySHAO, Yu-Yun; HONG, Ruey-Long.Anticancer research. 2008, Vol 28, Num 5B, pp 3115-3117, issn 0250-7005, 3 p.Article

High Circulating Endothelial Progenitor Levels Associated with Poor Survival of Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib Combined with Metronomic ChemotherapySHAO, Yu-Yun; LIN, Zhong-Zhe; CHEN, Te-Jung et al.Oncology. 2011, Vol 81, Num 2, pp 98-103, issn 0030-2414, 6 p.Article

Gastric Perforation Presenting as Empyema in a Patient with Pancreatic Cancer on Bevacizumab TreatmentSHAO, Yu-Yun; LIN, Zhong-Zhe; LIANG, Po-Chin et al.Anticancer research. 2009, Vol 29, Num 5, pp 1665-1667, issn 0250-7005, 3 p.Article

Dissimilar Immunohistochemical Expression of ERK and AKT between Paired Biopsy and Hepatectomy Tissues of Hepatocellular CarcinomaSHAO, Yu-Yun; CHEN, Chi-Long; HO, Ming-Chih et al.Anticancer research. 2012, Vol 32, Num 11, pp 4865-4870, issn 0250-7005, 6 p.Article

Metastasectomy of Krukenberg Tumors May Be Associated with Survival Benefits in Patients with Metastatic Gastric CancerLU, Li-Chun; SHAO, Yu-Yun; HSU, Chih-Hung et al.Anticancer research. 2012, Vol 32, Num 8, pp 3397-3401, issn 0250-7005, 5 p.Article

Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancerSHAO, Yu-Yun; SHAU, Wen-Yi; LIN, Zhong-Zhe et al.European journal of cancer (1990). 2013, Vol 49, Num 1, pp 106-114, issn 0959-8049, 9 p.Article

Impact of Baseline Hepatitis B Viral DNA Levels on Survival of Patients with Advanced Hepatocellular CarcinomaSHAO, Yu-Yun; CHEN, Pei-Jer; LIN, Zhong-Zhe et al.Anticancer research. 2011, Vol 31, Num 11, pp 4007-4011, issn 0250-7005, 5 p.Article

Efficacy, Safety, and Potential Biomarkers of Thalidomide plus Metronomic Chemotherapy for Advanced Hepatocellular CarcinomaSHAO, Yu-Yun; LIN, Zhong-Zhe; HSU, Chiun et al.Oncology. 2012, Vol 82, Num 1, pp 59-66, issn 0030-2414, 8 p.Article

Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinomaHSU, Chih-Hung; SHEN, Ying-Chun; LIN, Zhong-Zhe et al.Journal of hepatology. 2010, Vol 53, Num 1, pp 126-131, issn 0168-8278, 6 p.Article

Serum Insulin-Like Growth Factor-1 Levels Predict Outcomes of Patients with Advanced Hepatocellular Carcinoma Receiving Antiangiogenic TherapySHAO, Yu-Yun; HUANG, Chien-Chung; LIN, Shiou-Der et al.Clinical cancer research (Print). 2012, Vol 18, Num 14, pp 3992-3997, issn 1078-0432, 6 p.Article

Hospital Volume of Percutaneous Radiofrequency Ablation is Closely Associated With Treatment Outcomes for Patients With Hepatocellular CarcinomaLU, Li-Chun; SHAO, Yu-Yun; KUO, Raymond N. C et al.Cancer. 2013, Vol 119, Num 6, pp 1210-1216, issn 0008-543X, 7 p.Article

Survival of Patients with Small Cell Lung Carcinoma in TaiwanKUO, Yu-Hsuan; LIN, Zhong-Zhe; YANG, Yen-Yun et al.Oncology. 2012, Vol 82, Num 1, pp 19-24, issn 0030-2414, 6 p.Article

Early Alpha-Fetoprotein Response Predicts Treatment Efficacy of Antiangiogenic Systemic Therapy in Patients With Advanced Hepatocellular CarcinomaSHAO, Yu-Yun; LIN, Zhong-Zhe; HSU, Chiun et al.Cancer. 2010, Vol 116, Num 19, pp 4590-4596, issn 0008-543X, 7 p.Article

  • Page / 1